search
Back to results

Myocardial Infarction Prediction

Primary Purpose

Myocardial Infarction, Artificial Neural Network

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
ANN prediction of myocardial infarction
Sponsored by
Shiraz University of Medical Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Myocardial Infarction focused on measuring Myocardial infarction, artificial neural networks, Electrocardiography

Eligibility Criteria

40 Years - 72 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patient with chest pain refered to ER with nondiagnostic ECG

Exclusion Criteria:

  • 1) Absence of a history of myocardial infarction
  • 2) Absence of bundle branch block, Wolf-Parkinson-White abnormality, ventricular hypertrophy or previous ECG signs of myocardial infarction,
  • 3) Absence of a history of percutaneous coronary surgery or coronary artery bypass grafting,
  • 4) Absence of ECG abnormalities attributable to drugs such as digoxin or tricyclic antidepressants.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Placebo Comparator

    Active Comparator

    Arm Label

    those without MI in 2 weeks

    patient with MI

    Arm Description

    patient without MI in 2 weeks

    group with MI in 2 weeks

    Outcomes

    Primary Outcome Measures

    myocardial infarction

    Secondary Outcome Measures

    hospital admission due to cardiac events
    may be includes unstable angina, cardiac arrest or PCIor CABG

    Full Information

    First Posted
    May 24, 2013
    Last Updated
    June 4, 2013
    Sponsor
    Shiraz University of Medical Sciences
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01870258
    Brief Title
    Myocardial Infarction Prediction
    Official Title
    Prediction of Acute Myocardial Infarction With Artificial Neural Networks in Patients With Nondiagnostic Electrocardiogram
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2013
    Overall Recruitment Status
    Completed
    Study Start Date
    January 2011 (undefined)
    Primary Completion Date
    April 2012 (Actual)
    Study Completion Date
    June 2012 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Shiraz University of Medical Sciences

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    prediction of MI in patients with chest pain and nondiagnostic ECG was done in 2 weeks
    Detailed Description
    Myocardial infarction remains one the leading causes of mortality and morbidity and involves a high cost of care. Early prediction can be helpful in preventing the development of myocardial infarction with appropriate diagnosis and treatment. Artificial neural networks have opened new horizons in learning about the natural history of diseases and predicting cardiac disease. Methods: A total of 935 cardiac patients with chest pain and nondiagnostic electrocardiogram (ECG) were enrolled and followed for 2 weeks in two groups based on the appearance of myocardial infarction. Two types of data were used for all patients: nominal (clinical data) and quantitative (ECG findings). Two different artificial neural networks - radial basis function (RBF) and multi-layer perceptron (MLP) - were used.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Myocardial Infarction, Artificial Neural Network
    Keywords
    Myocardial infarction, artificial neural networks, Electrocardiography

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigatorOutcomes Assessor
    Allocation
    Non-Randomized
    Enrollment
    1100 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    those without MI in 2 weeks
    Arm Type
    Placebo Comparator
    Arm Description
    patient without MI in 2 weeks
    Arm Title
    patient with MI
    Arm Type
    Active Comparator
    Arm Description
    group with MI in 2 weeks
    Intervention Type
    Other
    Intervention Name(s)
    ANN prediction of myocardial infarction
    Other Intervention Name(s)
    sofware detected risk of new myocardial infraction
    Primary Outcome Measure Information:
    Title
    myocardial infarction
    Time Frame
    2 weeks
    Secondary Outcome Measure Information:
    Title
    hospital admission due to cardiac events
    Description
    may be includes unstable angina, cardiac arrest or PCIor CABG
    Time Frame
    2 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    40 Years
    Maximum Age & Unit of Time
    72 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: patient with chest pain refered to ER with nondiagnostic ECG Exclusion Criteria: 1) Absence of a history of myocardial infarction 2) Absence of bundle branch block, Wolf-Parkinson-White abnormality, ventricular hypertrophy or previous ECG signs of myocardial infarction, 3) Absence of a history of percutaneous coronary surgery or coronary artery bypass grafting, 4) Absence of ECG abnormalities attributable to drugs such as digoxin or tricyclic antidepressants.

    12. IPD Sharing Statement

    Learn more about this trial

    Myocardial Infarction Prediction

    We'll reach out to this number within 24 hrs